Share.Market Logo

Asston Pharmaceuticals Limited

  • Minimum Investment
    ₹2,30,000
  • Price Range
    ₹115 - ₹123
  • Issue Size
    ₹27.56 Cr
  • Lot Size
    2000 shares

This stock belongs to the SME (Small & Medium Enterprises) segment which usually has low liquidity and hence, is also riskier. It will be traded in a lot size of 2000 shares after listing.

Proceeds of this IPO to be used for

Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit

Funding the incremental working capital requirements

Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the company

General corporate purposes

Download RHP DocumentGet more in-depth details about this IPO.

Strengths & Weaknesses of Asston Pharmaceuticals Limited

Diverse product portfolio

The company offers a broad range of over 100 registered trademarks, including pediatric drugs, anti-tuberculosis treatments, and eye drops. With formulations like tablets, syrups, sachets, and injectables, the company caters to a wide spectrum of healthcare needs, making it a preferred partner for diverse markets

Strong formulation capability

The company has built deep expertise in formulation development across multiple therapeutic areas. Its in-house quality assurance and control facilities further enhance product quality. This capability has helped establish the company as a reliable player, especially in export markets

Reliable manufacturing network

The company works with five WHO-GMP certified contract manufacturers and also owns a unit at Ambernath with FDA approval for pharmaceutical production. These partnerships ensure industry-compliant output and operational flexibility. The company has developed strong ties with these manufacturers and is actively looking to expand its network further

Third-party dependency

The company operates its own manufacturing facility in Ambernath, Maharashtra, but relies on third-party manufacturers for certain products beyond tablets. While this contract manufacturing arrangement enhances production capacity, the company does not have exclusive or long-term agreements with these partners

Low entry barrier

The contract manufacturing space has low entry barriers, requiring no special certifications, making it easy for competitors to access the same manufacturers. The company currently has five tie-ups for medicine production, primarily for export. These manufacturers contribute significantly to overall revenue

Regional concentration

All of the company’s own and contract manufacturing facilities are located in Maharashtra, exposing it to geographic concentration risk. Any disruption—such as political unrest, labor issues, pandemics, regulatory challenges, or natural disasters in or around Maharashtra—could severely impact production and operations

Financials

Earnings Per Share

Earnings Per Share (EPS) is calculated by dividing a company’s net income by its average number of outstanding shares.

No Data

Balance Sheet

A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Particulars (In Cr)Y/Y Change
Total Current Assets--
Total Non-Current Assets--
Fixed assets--
Total assets--
Total Current Liabilities--
Total Non-Current Liabilities--
Total Capital Plus Liabilities--
Total Shareholder Funds--
Total Debt to Equity--

Cash Flow

The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Particulars (In Cr)Y/Y Change
Cash from Operating Activity--
Cash from Financing Activities--
Cash from Investing Activities--
Net Cash Flow--

About Asston Pharmaceuticals Limited

Asston Pharmaceuticals was incorporated on April 16, 2019. The company manufactures and exports pharmaceutical formulations and nutraceutical products under the brand “Asston.” Its product range includes tablets, capsules, syrups, ointments, gels, and sachets. It supplies both directly and through contract manufacturing, serving domestic and African markets from its facility in Maharashtra
  • Promoter
    Ashish Narayan Sakalkar
  • Promoter
    Saili Jayaram More
  • Promoter
    Sachin Chandrakant Badakh

Asston Pharmaceuticals Limited IPO FAQs

What is Asston Pharmaceuticals Limited IPO?

down-arrow
Asston Pharmaceuticals Limited IPO refers to the initial public offering of shares by Asston Pharmaceuticals Limited. It is a process by which the company offers its shares to the public for the first time, allowing individuals to become shareholders.

What is the issue size of Asston Pharmaceuticals Limited IPO?

down-arrow
For Asston Pharmaceuticals Limited IPO the issue size is ₹28 Cr. The issue size is the total value of the shares offered to the public. It represents the amount the company aims to raise through the IPO.

What is the minimum investment amount for the Asston Pharmaceuticals Limited IPO?

down-arrow
For Asston Pharmaceuticals Limited IPO the minimum investment is ₹2,30,000. The minimum investment for Asston Pharmaceuticals Limited IPO is the smallest amount an individual can invest to participate in the offering. It is usually determined by the company and regulatory requirements.

What is the lot size of Asston Pharmaceuticals Limited IPO?

down-arrow
For Asston Pharmaceuticals Limited IPO the lot size is 2000 shares. The lot size of Asston Pharmaceuticals Limited IPO refers to the number of shares that investors need to bid for and purchase in a single transaction. It is predetermined by the company and regulators.

How to apply for Asston Pharmaceuticals Limited IPO on Share.Market?

down-arrow
To apply for Asston Pharmaceuticals Limited IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the Asston Pharmaceuticals Limited IPO from the list and click on apply now. Place your bids or choose the Cut-off Price option. Enter your UPI ID and set up your mandate to place your application.

Can I pre-apply for Asston Pharmaceuticals Limited IPO?

down-arrow
Yes, investors can often pre-apply for some of the IPOs. Pre-application allows individuals to express their interest in participating in the IPO before the official subscription period begins. To pre- apply for Asston Pharmaceuticals Limited IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the IPO from the list and click on pre-apply now. Once the IPO opens for subscription you can enter your UPI ID and set up your mandate to place your application.

How many days is the IPO application window open?

down-arrow
The IPO application window typically remains open for 3 days, starting from the date of the IPO opening. However, this duration can vary depending on the specific IPO and the regulatory requirements.

Till what time can I apply for an IPO on the last day on Share.Market?

down-arrow
You can apply for the IPO till 3 PM on the last day of application on Share.Market.

What is the allotment date of Asston Pharmaceuticals Limited IPO?

down-arrow
For Asston Pharmaceuticals Limited IPO the allotment date is July 14, 2025. The allotment date of Asston Pharmaceuticals Limited IPO is the date on which shares are allocated to the successful bidders. It marks the distribution of shares to investors.

What are the open and close dates of Asston Pharmaceuticals Limited IPO?

down-arrow
For Asston Pharmaceuticals Limited IPO, the subscription opens on July 9, 2025 and closes on July 11, 2025. The open and close dates of an IPO indicate the period during which investors can submit their bids to participate in the offering.
Bidding Ongoing
-
Total Subscription
226.55x Oversubscribed
Trade
Bidding Ongoing
-
Total Subscription
226.55x Oversubscribed
Trade